COVID-19-associated thyroid diseases: Difference between revisions
Jump to navigation
Jump to search
Line 36: | Line 36: | ||
===Laboratory Findings=== | ===Laboratory Findings=== | ||
===X-ray=== | ===X-ray=== |
Revision as of 14:16, 14 July 2022
Template:COVID-19 thyroid disorders
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
COVID-19 has been found to affect several organs and body systems, including the endocrine system, with short-term and possible long-term consequences.
Historical Perspective
Classification
There is no established system for the classification of COVID-19-associated thyroid disorders.
Pathophysiology
Causes
Differentiating ((Page name)) from other Diseases
Epidemiology and Demographics
Risk Factors
There are no established risk factors for COVID-19-associated [[[thyroid diseases]].
Screening
There is insufficient evidence to recommend routine screening for COVID-19-associated thyroid diseases.